Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT02643303Phase 1/2Completed
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
Bladder CancerBreast CancerCutaneous T-Cell Lymphoma+8 more
StudychairStart date: 2016-12-28

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Craig L Slingluff, Jr., MD

University of Virginia

Very Similar
3 trials

Shared therapeutic areas:

MelanomaUrinary Bladder CancerBreast Cancer+8 more

Worked with same sponsors:

Cancer Research Institute, New York CityLudwig Institute for Cancer Research+1 more
Collaborated on 1 trial
Similarity Score114%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

MelanomaBreast CancerCancer of Kidney+1 more
Similarity Score11%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Carcinoma, Merkel CellProstate CancerSarcoma
Similarity Score8%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Prostate CancerBreast CancerCancer of Kidney
Similarity Score8%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Prostate CancerSolid TumorCancer of Kidney
Similarity Score8%

Steven A. Rosenberg, MD, PhD

NCI - Surgery Branch

Related
29 trials

Shared therapeutic areas:

Cancer of KidneyBreast CancerSarcoma
Similarity Score8%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Breast CancerSarcomaSolid Tumor
Similarity Score8%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Breast CancerProstate Cancer
Similarity Score5%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

Prostate CancerBreast Cancer
Similarity Score5%

Lin Shen, MD

Peking University Cancer Hospital & Institute

Related
20 trials

Shared therapeutic areas:

Solid TumorBreast Cancer
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02643303Phase 1/2StudyChair

A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers

Bladder CancerBreast CancerCutaneous T-Cell Lymphoma+8 more
Completed

All 1 trials loaded